Synthetic method for ezetimibe intermediate

A synthetic method, ezetimibe technology, applied in the direction of organic chemistry, can solve the problems of long synthetic route and high synthetic cost, and achieve the effect of low synthetic cost, short synthetic route and simple operation

Inactive Publication Date: 2016-01-13
WUXI FORTUNE PHARMA
View PDF5 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] It can be seen that in the prior art, the key intermediate for the synthesis of ezetimibe (4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1 ,3-Oxazo

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthetic method for ezetimibe intermediate
  • Synthetic method for ezetimibe intermediate
  • Synthetic method for ezetimibe intermediate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0019] The present invention will be described in detail below in conjunction with various embodiments, but it should be noted that these embodiments are not limitations of the present invention, and those of ordinary skill in the art can make functional, method, or structural equivalent transformations or replacements based on these embodiments. , all fall within the protection scope of the present invention.

[0020] Unless otherwise specified in the description, the components and raw materials in each example of the present invention are of analytical grade. In addition, "g" in each embodiment is the weight unit "gram"; "h" is the time unit "hour"; "ml" is the volume unit "milliliter"; "room temperature" is 23°C; Liquid Chromatographic Detection". "Concentration" is mass percentage.

[0021] The present invention adopts "one-pot method" to synthesize ezetimibe intermediate (4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1, 3-Oxazolane-2-one (II) has the adv...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a synthetic method for an ezetimibe intermediate. The synthetic method comprises: by taking a compound I as a raw material, mixing the compound I with a reaction solution; under the action of an acid-binding agent, firstly activating the compound I by pivaloyl chloride; then coupling the compound with S-4-phenyl-2-oxazolidinone; then carrying out reduction reaction through (R)-2-mehtyl-CBS-oxazole borane; and then carrying out post-treatment to prepare (4S)-3-[(5S)-5-(4-fluorophenyl-5-hydroxyl valeryl)-4-phenyl-1,3- azacyclocyclopentane-2-(one) (II), wherein the formula is as shown in the description, and the reaction solution comprises tetrahydrofuran, chloroform, dioxane or dichloromethane. The synthetic method for the ezetimibe intermediate disclosed by the invention has the advantages of being simple to operate, short in synthetic line and relatively low in synthetic cost, and is suitable for large-scaled industrial production.

Description

technical field [0001] The invention relates to the technical field of medicinal chemistry, in particular to an ezetimibe intermediate (4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl -1,3-Oxazolane-2-one (II) synthesis method. Background technique [0002] Ezetimibe is the first cholesterol absorption inhibitor approved by the U.S. FDA. It was jointly developed by Schering-Plough and Merck. It was first approved for marketing in the U.S. in 2002. There are many kinds of drugs for lowering blood lipids in the market. As a new type of cholesterol absorption inhibitor, ezetimibe not only has remarkable effect, but also has less side effects. It can also be used in combination with statins. The effect is good and the market is huge. [0003] (4S)-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolane-2-one (Ⅱ) It is the key intermediate in the route of synthesizing ezetimibe. The existing synthetic routes are two-step synthesis, and the reaction for...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D263/22
CPCC07D263/22
Inventor 王庆林王涛王彬彬米靖宇徐建国张莹虞佳媛成梁
Owner WUXI FORTUNE PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap